DNA Nanocage-Mediated Aspirin Delivery Mitigates Excitotoxicity and Promotes Neuroprotection in Ischemic Stroke-Induced Zebrafish
Krupa KansaraiD, Shaivee ChokshiiD, Keya JantraniaiD, Sandip MandaliD, Prabal Kumar MaitiiD, Ashutosh KumariD, Dhiraj Devidas BhatiaiD
Abstract
Oxidative stress, apoptosis, excitotoxicity, and compromised neuronal function are the hallmarks of ischaemic stroke, a major cause of neurological impairment. Because of their controlled-release properties and biocompatibility, DNA tetrahedron nanostructures (TD) offer a viable platform for targeted drug delivery. In this work, we used a zebrafish larval model of ischaemic stroke to assess the neuroprotective potential of TD-mediated aspirin administration and investigated the TD:Aspirin complexation modes using molecular dynamics (MD) simulations. In addition to morphological abnormalities, elevated reactive oxygen species (ROS), thrombus formation, intracellular calcium accumulation, and dysregulated expression of neuroprotective and apoptotic genes, stroke induction resulted in significant behavioural deficits, including decreased locomotor activity, increased latency, and erratic swimming. Treatment with TD:Aspirin, especially at a 1:100 ratio, markedly improved locomotor behaviour, restored production of BDNF, GDNF, MBP, -tubulin, GRIN2B, SLC8A, NOS1, and caspases, normalised heart rate, lowered ROS generation and apoptosis, and decreased thrombus and calcium deposition. TD:Aspirin showed better efficacy than free Aspirin and TD-only groups, perhaps as a result of improved stability, bioavailability, and sustained release. These results demonstrate the potential of drug delivery via DNA nanocages as a novel therapeutic approach for ischaemic stroke, offering neuroprotection, functional recovery, and neuronal homeostasis restoration. TOC GraphicDNA Nanocage-Mediated Aspirin Delivery Mitigates Excitotoxicity and Promotes Neuroprotection in Ischemic Stroke-Induced Zebrafish O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=140 SRC="FIGDIR/small/696221v1_ufig1.gif" ALT="Figure 1"> View larger version (56K): org.highwire.dtl.DTLVardef@18dd327org.highwire.dtl.DTLVardef@21b8b4org.highwire.dtl.DTLVardef@1e53283org.highwire.dtl.DTLVardef@5771e6_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Targeting lipid nanoparticles to the blood brain barrier to ameliorate acute ischemic stroke
J. Nong, P. M. Glassman, … O. A. Marcos-Contreras·bioRxiv·Jun 12, 2023
- Methotrexate carried in lipid core nanoparticles reduces microglial activation and is neuroprotective after ischemic cortical stroke
Edmundo Luís Rodrigues Pereira, Michelle N.C. Dias, … Walace Gomes‐Leal·bioRxiv·Jun 16, 2020
- Adropin confers neuroprotection and promotes functional recovery from ischemic stroke
Changjun Yang, Bianca P. Lavayen, … Eduardo Candelario‐Jalil·bioRxiv·Sep 16, 2021
- Functional coupling of TRPM2 and NMDARs exacerbates excitotoxicity in ischemic brain injury
Pengyu Zong, Jianlin Feng, … Lixia Yue·bioRxiv·Jul 29, 2021
- Shear stress targeted delivery of nitroglycerin to brain collaterals improves ischaemic stroke outcome
Magdalena Litman, Sara Azarpeykan, … Daniel J. Beard·Advanced SciencePeer-reviewed·Aug 13, 2025
- Intra-arterial Deoxyribonuclease therapy improves stroke outcomes in aged mice
Junxiang Yin, Michael Wu, … Michael F. Waters·CNS Neuroscience & TherapeuticsPeer-reviewed·Jun 1, 2025